Table 1.
Patient and imaging characteristics
| No fracture (n=55) | Fracture (n=27) | p Value | |
|---|---|---|---|
| Median (Range) | Median (Range) | ||
|
|
|||
| Age, year | 58 (32, 82) | 62 (35, 86) | 0.355 |
| SUVmax | 4.8 (1.3, 16.5) | 9.9 (1.7, 27) | <.001 |
| SUVmean | 2.8 (0.8, 8.7) | 4.1 (1.5, 13.8) | 0.001 |
| Tumor Volume (cm^3) | 9 (1.4, 69.6) | 52.1 (4, 121) | <.001 |
| Total Lesion Glycolysis | 27.2 (2.66, 605.52) | 184.98 (8.4, 938.4) | <.001 |
| N (%) | N (%) | ||
|
|
|||
| Histology | |||
| Ductal | 40 (73%) | 20 (74%) | 0.999 |
| Lobular | 9 (16%) | 4 (15%) | |
| Both | 6 (11%) | 3 (11%) | |
| Histology Grade | |||
| 2 | 12 (26%) | 7 (30%) | 0.776 |
| 3 | 35 (74%) | 16 (70%) | |
| N/A* | 8 | 4 | |
| Radiation to Lesion | |||
| No | 51 (93%) | 20 (74%) | 0.035 |
| Yes | 4 (7%) | 7 (26%) | |
| Location | |||
| Head/Neck | 4 (7%) | 9 (33%) | 0.006 |
| Troch | 12 (22%) | 7 (26%) | |
| Both | 39 (71%) | 11 (41%) | |
| Lesion Laterality | |||
| Left | 24 (44%) | 9 (33%) | 0.474 |
| Right | 31 (56%) | 18 (67%) | |
| Receptor Status | |||
| ERPR+/HER2− | 52 (95%) | 22 (81%) | 0.020 |
| HER2+ | 3 (5%) | 1 (4%) | |
| TN | 0 (0%) | 4 (15%) | |
*
Unknown was not included in the test.